Bisphosphonates market seen reaching $7.45 billion by 2030
The global bisphosphonates market is forecast to grow from $6.03 billion in 2026 to $7.45 billion by 2030, driven by aging populations, rising osteoporosis cases and wider use of long-acting and generic therapies. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.
Why it matters: - Bisphosphonates are a core treatment for osteoporosis and other bone-weakening conditions, so market growth tracks demand for fracture prevention and bone health care. - The market outlook points to broader use of these drugs as aging populations expand and osteoporosis becomes more common worldwide.
What happened: - The Business Research Company published its Bisphosphonates Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report values the bisphosphonates market at $6.03 billion in 2026, up from $5.7 billion in 2025. - The market is forecast to reach $7.45 billion by 2030, implying a 5.4% CAGR. - The company said North America was the largest regional market in 2025. - The Asia-Pacific region is expected to post the fastest growth during the forecast period.
The details: - Historical market growth from 2025 to 2026 reflects a 5.8% CAGR. - The report ties that growth to a larger elderly population, more postmenopausal osteoporosis cases, physician-led bone density screenings, hospital-based osteoporosis management and wider use of injectable bisphosphonate therapies. - Future demand is expected to come from more older adults, expansion of home-based osteoporosis care, stronger preference for long-acting dosage forms, greater awareness of bone health and more generic bisphosphonate use. - The report highlights rising demand for osteoporosis treatments, more use of long-acting injectable therapies, growing generic availability, a stronger focus on fracture prevention and more combination therapies. - Bisphosphonates work by inhibiting osteoclast activity, which slows bone loss. - The drugs are used for osteoporosis, Paget’s disease and bone metastases linked to cancer. - Bisphosphonates help raise bone mineral density and reduce fractures, especially in postmenopausal women and older adults. - A free sample of the report is available here. - The full report is available here.
Between the lines: - Rising osteoporosis prevalence is a key market driver because more fractures increase demand for prevention and treatment. - Healthy Bones Australia said roughly 193,482 osteoporosis- and osteopenia-related fractures occurred in 2023, with that total expected to rise 34% to 237,632 by 2033. - Research activity is also supporting market growth as clinical trials expand across the industry. - ABPI data showed industry-sponsored clinical trials in the UK rose from 411 in 2022 to 426 in 2023. - The report signals a market shift toward easier-to-use therapies and broader access through generics, which could support treatment adoption.
What's next: - The market is expected to keep growing through 2030 as osteoporosis care moves further into home-based settings and long-acting formulations gain traction. - Greater generic penetration and more combination therapy development could reshape competition in the years ahead. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel dashboards, market hotspots infographics and updated technology and trend analysis.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
The Australia Globe
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.